Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
ENTPD1/CD39 is a promising therapeutic target in oncology
HTML
Details
Locations
Year:
2012
Type:
review
Source:
Oncogene
DOI:
10.1038/onc.2012.269
Authors:
J Bastid,
A Cottalorda-Regairaz,
G Alberici,
N Bonnefoy,
J-F Eliaou,
A Bensussan
show all 6
Institutions:
OREGA Biotech (France),
Lyon 1 Université,
Inserm,
Université de Lyon,
Centre Hospitalier Universitaire de Montpellier,
Université Montpellier 1,
Sorbonne Paris Cité,
Université Paris Diderot,
HIPI - Immunologie humaine, physiopathologie et immunithérapie
show all 9
Language:
English
Topic:
Adenosine and Purinergic Signaling
Subfield:
Physiology
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W1969645166
FWCI:
1.642
Cites:
88
Cited by:
218
Related to:
9